310 related articles for article (PubMed ID: 20531296)
1. The activating mutation R201C in GNAS promotes intestinal tumourigenesis in Apc(Min/+) mice through activation of Wnt and ERK1/2 MAPK pathways.
Wilson CH; McIntyre RE; Arends MJ; Adams DJ
Oncogene; 2010 Aug; 29(32):4567-75. PubMed ID: 20531296
[TBL] [Abstract][Full Text] [Related]
2. GNAS mutation as an alternative mechanism of activation of the Wnt/β-catenin signaling pathway in gastric adenocarcinoma of the fundic gland type.
Nomura R; Saito T; Mitomi H; Hidaka Y; Lee SY; Watanabe S; Yao T
Hum Pathol; 2014 Dec; 45(12):2488-96. PubMed ID: 25288233
[TBL] [Abstract][Full Text] [Related]
3. Mutated K-ras(Asp12) promotes tumourigenesis in Apc(Min) mice more in the large than the small intestines, with synergistic effects between K-ras and Wnt pathways.
Luo F; Brooks DG; Ye H; Hamoudi R; Poulogiannis G; Patek CE; Winton DJ; Arends MJ
Int J Exp Pathol; 2009 Oct; 90(5):558-74. PubMed ID: 19765110
[TBL] [Abstract][Full Text] [Related]
4.
Tang C; Zhong C; Zhu J; Yuan F; Yang J; Xu Y; Ma C
Oncol Res; 2024; 32(6):1079-1091. PubMed ID: 38827318
[TBL] [Abstract][Full Text] [Related]
5. Gsα Controls Cortical Bone Quality by Regulating Osteoclast Differentiation via cAMP/PKA and β-Catenin Pathways.
Ramaswamy G; Kim H; Zhang D; Lounev V; Wu JY; Choi Y; Kaplan FS; Pignolo RJ; Shore EM
Sci Rep; 2017 Mar; 7():45140. PubMed ID: 28338087
[TBL] [Abstract][Full Text] [Related]
6. GNAS
Ideno N; Yamaguchi H; Ghosh B; Gupta S; Okumura T; Steffen DJ; Fisher CG; Wood LD; Singhi AD; Nakamura M; Gutkind JS; Maitra A
Gastroenterology; 2018 Nov; 155(5):1593-1607.e12. PubMed ID: 30142336
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological and molecular correlations in traditional serrated adenoma.
Sekine S; Yamashita S; Yamada M; Hashimoto T; Ogawa R; Yoshida H; Taniguchi H; Kojima M; Ushijima T; Saito Y
J Gastroenterol; 2020 Apr; 55(4):418-427. PubMed ID: 32052185
[TBL] [Abstract][Full Text] [Related]
8. Activation of cyclic AMP signaling leads to different pathway alterations in lesions of the adrenal cortex caused by germline PRKAR1A defects versus those due to somatic GNAS mutations.
Almeida MQ; Azevedo MF; Xekouki P; Bimpaki EI; Horvath A; Collins MT; Karaviti LP; Jeha GS; Bhattacharyya N; Cheadle C; Watkins T; Bourdeau I; Nesterova M; Stratakis CA
J Clin Endocrinol Metab; 2012 Apr; 97(4):E687-93. PubMed ID: 22259056
[TBL] [Abstract][Full Text] [Related]
9. Mutant GNAS drives pancreatic tumourigenesis by inducing PKA-mediated SIK suppression and reprogramming lipid metabolism.
Patra KC; Kato Y; Mizukami Y; Widholz S; Boukhali M; Revenco I; Grossman EA; Ji F; Sadreyev RI; Liss AS; Screaton RA; Sakamoto K; Ryan DP; Mino-Kenudson M; Castillo CF; Nomura DK; Haas W; Bardeesy N
Nat Cell Biol; 2018 Jul; 20(7):811-822. PubMed ID: 29941929
[TBL] [Abstract][Full Text] [Related]
10. Wnt-driven LARGE2 mediates laminin-adhesive O-glycosylation in human colonic epithelial cells and colorectal cancer.
Dietinger V; García de Durango CR; Wiechmann S; Boos SL; Michl M; Neumann J; Hermeking H; Kuster B; Jung P
Cell Commun Signal; 2020 Jun; 18(1):102. PubMed ID: 32586342
[TBL] [Abstract][Full Text] [Related]
11. Intestinal epithelial cell-specific CD98 expression regulates tumorigenesis in Apc(Min/+) mice.
Nguyen HT; Dalmasso G; Yan Y; Laroui H; Charania M; Ingersoll S; Ayyadurai S; Zhang Y; Sitaraman S; Merlin D
Lab Invest; 2012 Aug; 92(8):1203-12. PubMed ID: 22641098
[TBL] [Abstract][Full Text] [Related]
12. A novel
Watanabe K; Nakamura T; Onodera S; Saito A; Shibahara T; Azuma T
Tumour Biol; 2020 Sep; 42(9):1010428320962588. PubMed ID: 32996421
[TBL] [Abstract][Full Text] [Related]
13. Abnormalities of cAMP signaling are present in adrenocortical lesions associated with ACTH-independent Cushing syndrome despite the absence of mutations in known genes.
Bimpaki EI; Nesterova M; Stratakis CA
Eur J Endocrinol; 2009 Jul; 161(1):153-61. PubMed ID: 19429701
[TBL] [Abstract][Full Text] [Related]
14. Coding GNAS mutations leading to hormone resistance impair in vitro agonist- and cholera toxin-induced adenosine cyclic 3',5'-monophosphate formation mediated by human XLalphas.
Linglart A; Mahon MJ; Kerachian MA; Berlach DM; Hendy GN; Jüppner H; Bastepe M
Endocrinology; 2006 May; 147(5):2253-62. PubMed ID: 16484323
[TBL] [Abstract][Full Text] [Related]
15. GNAS(R201H) and Kras(G12D) cooperate to promote murine pancreatic tumorigenesis recapitulating human intraductal papillary mucinous neoplasm.
Taki K; Ohmuraya M; Tanji E; Komatsu H; Hashimoto D; Semba K; Araki K; Kawaguchi Y; Baba H; Furukawa T
Oncogene; 2016 May; 35(18):2407-12. PubMed ID: 26257060
[TBL] [Abstract][Full Text] [Related]
16. Induction of specific phosphodiesterase isoforms by constitutive activation of the cAMP pathway in autonomous thyroid adenomas.
Persani L; Lania A; Alberti L; Romoli R; Mantovani G; Filetti S; Spada A; Conti M
J Clin Endocrinol Metab; 2000 Aug; 85(8):2872-8. PubMed ID: 10946896
[TBL] [Abstract][Full Text] [Related]
17. Serine-threonine Kinase Receptor-Associated Protein is a Critical Mediator of APC Mutation-Induced Intestinal Tumorigenesis Through a Feed-Forward Mechanism.
Vu T; Datta A; Banister C; Jin L; Yuan G; Samuel T; Bae S; Eltoum IE; Manne U; Zhang B; Welner RS; Mitra K; Buckhaults P; Datta PK
Gastroenterology; 2022 Jan; 162(1):193-208. PubMed ID: 34520730
[TBL] [Abstract][Full Text] [Related]
18. Osteoblast-specific expression of the fibrous dysplasia (FD)-causing mutation Gsα(R201C) produces a high bone mass phenotype but does not reproduce FD in the mouse.
Remoli C; Michienzi S; Sacchetti B; Consiglio AD; Cersosimo S; Spica E; Robey PG; Holmbeck K; Cumano A; Boyde A; Davis G; Saggio I; Riminucci M; Bianco P
J Bone Miner Res; 2015 Jun; 30(6):1030-43. PubMed ID: 25487351
[TBL] [Abstract][Full Text] [Related]
19. Different roles of GNAS and cAMP signaling during early and late stages of osteogenic differentiation.
Zhang S; Kaplan FS; Shore EM
Horm Metab Res; 2012 Sep; 44(10):724-31. PubMed ID: 22903279
[TBL] [Abstract][Full Text] [Related]
20. GNAS mutations are present in colorectal traditional serrated adenomas, serrated tubulovillous adenomas and serrated adenocarcinomas with adverse prognostic features.
Liu C; McKeone DM; Walker NI; Bettington ML; Leggett BA; Whitehall VLJ
Histopathology; 2017 Jun; 70(7):1079-1088. PubMed ID: 28164369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
